Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
Denise Hilfiker‐Kleiner(Medizinische Hochschule Hannover), Johann Bauersachs(Medizinische Hochschule Hannover), Verena Stangl(Deutsches Herzzentrum der Charité), Michael Böhm(Saarland University), Edith Podewski(Medizinische Hochschule Hannover), Ingrid Kindermann(Baker Heart and Diabetes Institute), Roman Pfister(University of Cologne), Karen Sliwa(University of Cape Town), Ralf Westenfeld(Düsseldorf University Hospital), Annegret Franke(Leipzig University), Marziel Schwarzkopf(Leipzig University), Axel Schlitt(Martin Luther University Halle-Wittenberg), Christiane E. Angermann(Universitätsklinikum Würzburg), Philipp Ehlermann(Heidelberg University), Dominik Berliner(Medizinische Hochschule Hannover), Dieter Fischer(Medizinische Hochschule Hannover), Jens Vogel‐Claussen(Medizinische Hochschule Hannover), Johannes Schwab(MRC Laboratory of Molecular Biology), Guido Michels(Sankt-Antonius-Hospital Eschweiler), Uwe Kühl(German Centre for Cardiovascular Research)
Cited by 334
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k